Direct synthesis of N-aryl/alkyl 3-carbonylpyrroles from the Morita–Baylis–Hillman acetate of 2,2-dimethoxyacetaldehyde and a primary amine

Luxia Guo, Jiaqi Li, Luigi Vaccaro, Minghao Li and Yanlong Gu

Green Chem., 2021, 23, 9465
DOI: 10.1039/D1GC03635A

Synthetic cannabinoid CUMYL-4CN-BINACA induces oxidative stress, ER stress, and apoptosis in brain and testicular tissues of male albino rats

Erdem Eren Demir, Cihan Gur, Turgay Sisman, Ayse Lafzi and Özkan Aksakal

Food and Chemical Toxicology, 2025, 204, 115617
DOI: 10.1016/j.fct.2025.115617

Synthetic cannabinoids and potential cardiac arrhythmia risk: an important message for drug users

Jules C. Hancox, Nicola J. Kalk and Graeme Henderson

Therapeutic Advances in Drug Safety, 2020, 11
DOI: 10.1177/2042098620913416

Potential Mechanisms Underlying the Deleterious Effects of Synthetic Cannabinoids Found in Spice/K2 Products

Balapal S. Basavarajappa and Shivakumar Subbanna

Brain Sciences, 2019, 9, 14
DOI: 10.3390/brainsci9010014

New synthetic cannabinoids and the potential for cardiac arrhythmia risk

Jules C. Hancox, Caroline S. Copeland, Stephen C. Harmer and Graeme Henderson

Journal of Molecular and Cellular Cardiology Plus, 2023, 6, 100049
DOI: 10.1016/j.jmccpl.2023.100049

Critical Illness Secondary to Synthetic Cannabinoid Ingestion

Ismini Kourouni, Bashar Mourad, Hassan Khouli, Janet M. Shapiro and Joseph P. Mathew

JAMA Netw Open, 2020, 3, e208516
DOI: 10.1001/jamanetworkopen.2020.8516

The electrophysiological effects of cannabidiol on action potentials and transmembrane potassium currents in rabbit and dog cardiac ventricular preparations

Leila Topal, Muhammad Naveed, Péter Orvos, Bence Pászti, János Prorok, Ákos Bajtel, Tivadar Kiss, Boglárka Csupor-Löffler, Dezső Csupor, István Baczkó, András Varró, László Virág and Norbert Jost

Arch Toxicol, 2021, 95, 2497
DOI: 10.1007/s00204-021-03086-0

Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors

Yiming Bo, Xin Zhao and Liliang Li

Clinical Science, 2024, 138, 413
DOI: 10.1042/CS20231156

Electrocardiographic alterations in patients consuming synthetic cannabinoids

Hayriye M Ozturk, Mehmet Erdogan, Yakup Alsancak, Mikail Yarlioglues, Mustafa Duran, M Hamid Boztas, Sani N Murat and Selcuk Ozturk

J Psychopharmacol, 2018, 32, 296
DOI: 10.1177/0269881117736918

Synthetic Cannabinoids and Cardiac Arrhythmia Risk: Review of the Literature

Hayriye Mihrimah Ozturk, Ertan Yetkin and Selcuk Ozturk

Cardiovasc Toxicol, 2019, 19, 191
DOI: 10.1007/s12012-019-09522-z

Pain medication and long QT syndrome

Christoph Klivinyi and Helmar Bornemann-Cimenti

Korean J Pain, 2018, 31, 3
DOI: 10.3344/kjp.2018.31.1.3

Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy

Bogdan Ionel Tamba, Gabriela Dumitrita Stanciu, Cristina Mariana Urîtu, Elena Rezus, Raluca Stefanescu, Cosmin Teodor Mihai, Andrei Luca, Gabriela Rusu-Zota, Maria-Magdalena Leon-Constantin, Elena Cojocaru, Bogdan Gafton and Teodora Alexa-Stratulat

Medicina, 2020, 56, 24
DOI: 10.3390/medicina56010024

Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use

John R. Richards

J Cardiovasc Pharmacol Ther, 2020, 25, 508
DOI: 10.1177/1074248420935743

Relationship between KCNQ1 (LQT1) and KCNH2 (LQT2) gene mutations and sudden death during illegal drug use

Sayaka Nagasawa, Hisako Saitoh, Shiori Kasahara, Fumiko Chiba, Suguru Torimitsu, Hiroko Abe, Daisuke Yajima and Hirotaro Iwase

Sci Rep, 2018, 8
DOI: 10.1038/s41598-018-26723-8

2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo

Kyung Sik Yoon, Jaesuk Yun, Young-Hoon Kim, Jisoon Shin, Sung Jin Kim, Jung-Wook Seo, Sung-Ae Hyun, Soo Kyung Suh and Hye Jin Cha

Toxicology Letters, 2019, 304, 50
DOI: 10.1016/j.toxlet.2019.01.004

25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: possible involvement of p21 (CDC42/RAC)-activated kinase 1

Kyung Sik Yoon, Sun Mi Gu, Hye Jin Cha, Young-Hoon Kim, Jaesuk Yun and Jin-Moo Lee

Drug and Chemical Toxicology, 2022, 45, 898
DOI: 10.1080/01480545.2020.1784924

Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists

Eun Yong Chung, Hye Jin Cha, Hyun Kyu Min and Jaesuk Yun

Arch. Pharm. Res., 2021, 44, 402
DOI: 10.1007/s12272-021-01326-6

Cardiac effects of 5F-Cumyl-PEGACLONE

Nicole Esdar, Evelyn Pawlik, Simon B. Eickhoff, Annika Raupach, Stefanie Ritz-Timme and Felix Mayer

Int J Legal Med, 2024, 138, 823
DOI: 10.1007/s00414-023-03146-3

Effects of Δ9-Tetrahydrocannabinol and the Aminoalkylindole K2/Spice Constituent JWH-073 on Cardiac Tissue and Mesenteric Vascular Reactivity

Chris S. Breivogel, Bonnie M. Brenseke, Khalil Eldeeb, Katlyn Nichols, Amreen Jonas, Artik H. Mistry, Laura Barbalato, Nicholas Luibil, Allyn C. Howlett, Sandra Leone-Kabler, Rob P.H. Hilgers and Victor M. Pulgar

Cannabis and Cannabinoid Research, 2024, 9, e1056
DOI: 10.1089/can.2022.0325

Mitigating the Risk of QTc Prolongation When Using Haloperidol for Acute Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents and Young Adults

Sandra Merino, Lissette Tordera, Allison Jun and Sun Yang

JCM, 2024, 14, 163
DOI: 10.3390/jcm14010163

Acute and subacute cardiovascular effects of synthetic cannabinoid JWH-018 in rat

Onural Ozhan, Necip Ermis, Osman Celbis, Emine Samdanci, Semih Petekkaya, Mucahit Oruc, Ozcan Soylu, Pelin Koparir, Ahmet Acet and Hakan Parlakpinar

Forensic Toxicol, 2025, 43, 266
DOI: 10.1007/s11419-025-00720-9

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

Richard C. Kevin, Elizabeth A. Cairns, Rochelle Boyd, Jonathon C. Arnold, Michael T. Bowen, Iain S. McGregor and Samuel D. Banister

Front. Psychiatry, 2022, 13
DOI: 10.3389/fpsyt.2022.1048836

The Old and the New: Cardiovascular and Respiratory Alterations Induced by Acute JWH-018 Administration Compared to Δ9-THC—A Preclinical Study in Mice

Beatrice Marchetti, Sabrine Bilel, Micaela Tirri, Raffaella Arfè, Giorgia Corli, Elisa Roda, Carlo Alessandro Locatelli, Elena Cavarretta, Fabio De Giorgio and Matteo Marti

IJMS, 2023, 24, 1631
DOI: 10.3390/ijms24021631

Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications

Arianna Giorgetti, Jennifer Pascali, Paolo Fais, Guido Pelletti, Andrea Gabbin, Giorgia Franchetti, Giovanni Cecchetto and Guido Viel

Life, 2021, 11, 440
DOI: 10.3390/life11050440

Prevalence of cardiac arrhythmias in cannabis use disorder related hospitalizations in teenagers from 2003 to 2016 in the United States

Krishna Kishore Umapathi, Aravind Thavamani, Harshitha Dhanpalreddy and Hoang H Nguyen

EP Europace, 2021, 23, 1302
DOI: 10.1093/europace/euab033

2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system

Kyung Sik Yoon, Hye Jin Cha, Sun Ok Choi and Jin-Moo Lee

Toxicology Letters, 2022, 355, 160
DOI: 10.1016/j.toxlet.2021.11.016

Cardiac Arrhythmias Among Teenagers Using Cannabis in the United States

Kamleshun Ramphul and Jyotsnav Joynauth

The American Journal of Cardiology, 2019, 124, 1966
DOI: 10.1016/j.amjcard.2019.09.002

The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations

Péter Orvos, Bence Pászti, Leila Topal, Péter Gazdag, János Prorok, Alexandra Polyák, Tivadar Kiss, Edit Tóth-Molnár, Boglárka Csupor-Löffler, Ákos Bajtel, András Varró, Judit Hohmann, László Virág and Dezső Csupor

Sci Rep, 2020, 10
DOI: 10.1038/s41598-020-73165-2

Drug-specific risk of severe QT prolongation following acute drug overdose

Sharan L. Campleman, Jeffery Brent, Anthony F. Pizon, Joshua Shulman, Paul Wax and Alex F. Manini

Clinical Toxicology, 2020, 58, 1326
DOI: 10.1080/15563650.2020.1746330

Methoxetamine Induces Cytotoxicity in H9c2 Cells: Possible Role of p21 Protein (Cdc42/Rac)-Activated Kinase 1

Kyung Sik Yoon, Sun Mi Gu, Santosh Lamichhane, Kyoung Moon Han, Jisoon Shin, Young-Hoon Kim, Soo Kyung Suh, Hye Jin Cha and Jaesuk Yun

Cardiovasc Toxicol, 2019, 19, 229
DOI: 10.1007/s12012-018-9489-4

The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications

Austin T. Jones, Alaa Marwan Abu Taha and Grover P. Miller

Neuroscience & Biobehavioral Reviews, 2025, 170, 106043
DOI: 10.1016/j.neubiorev.2025.106043

How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe

Raquel Santos‐Toscano, Amira Guirguis and Colin Davidson

Brit J Clinical Pharma, 2020, 86, 452
DOI: 10.1111/bcp.14224

Torsades de Pointes due to Excessive Marijuana Use in a Susceptible Patient

Vivek D. Shah, Adeba Mohammad, Shuktika Nandkeolyar, Liset Stoletniy, Tahmeed Contractor and Tong Liu

Case Reports in Cardiology, 2021, 2021, 1
DOI: 10.1155/2021/6621496

Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

Jolanta Weresa, Anna Pędzińska-Betiuk, Krzysztof Mińczuk, Barbara Malinowska and Eberhard Schlicker

Cells, 2022, 11, 1142
DOI: 10.3390/cells11071142

Medicinal Use of Synthetic Cannabinoids—a Mini Review

P. Muralidhar Reddy, Nancy Maurya and Bharath Kumar Velmurugan

Curr Pharmacol Rep, 2019, 5, 1
DOI: 10.1007/s40495-018-0165-y

The Risk of QTc Prolongation with Antiemetics in the Palliative Care Setting: A Narrative Review

Elizabeth M. Gavioli, Nerli Guardado, Farah Haniff, Nouran Deiab and Etty Vider

Journal of Pain & Palliative Care Pharmacotherapy, 2021, 35, 125
DOI: 10.1080/15360288.2021.1900491